Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 81 | $1.80 | $145.80 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,115 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 15, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.89 | $154.98 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,034 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 14, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.86 | $152.52 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,952 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 13, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.80 | $147.60 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,870 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 12, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 87 | $1.77 | $153.99 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,788 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 11, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 82 | $1.85 | $151.70 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,701 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 08, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.83 | $131.76 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,619 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 07, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 34 | $1.65 | $56.10 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,547 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 06, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.70 | $122.40 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,513 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 05, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.69 | $121.68 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,441 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 04, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 64 | $1.72 | $110.08 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,369 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 01, 2023 Filed Dec 28, 2023 22:11 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.69 | $121.68 |
DisclosureSEC source: 0001214659-23-017035 · marketforms-63938.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,305 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 30, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 62 | $1.66 | $102.92 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,233 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 29, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 32 | $1.73 | $55.36 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,171 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 28, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.68 | $42.00 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,139 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 27, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 72 | $1.86 | $133.92 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,114 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 22, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.74 | $95.70 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,042 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 21, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 25 | $1.76 | $44.00 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,987 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 20, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 53 | $1.70 | $90.10 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,962 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 17, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.83 | $100.65 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,909 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 16, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $1.73 | $22.49 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,854 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 15, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.78 | $97.90 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,841 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 14, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.73 | $95.15 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,786 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 13, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 46 | $1.75 | $80.50 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,731 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 10, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.77 | $97.35 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,685 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 09, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.82 | $100.10 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,630 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 08, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.00 | $110.00 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,575 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 07, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 19 | $2.01 | $38.19 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,520 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 06, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.03 | $111.65 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,501 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 03, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.06 | $113.30 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,446 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 02, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.97 | $108.35 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,391 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| November 01, 2023 Filed Dec 6, 2023 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.85 | $101.75 |
DisclosureSEC source: 0001214659-23-016101 · marketforms-63725.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,336 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. Read SEC document |
| October 31, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.01 | $110.55 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 22 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,281 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 30, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 51 | $2.04 | $104.04 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,226 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 27, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.98 | $108.90 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,175 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 26, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.99 | $109.45 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,120 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 25, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.99 | $109.45 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,065 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 24, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.10 | $115.50 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,010 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 23, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 50 | $2.08 | $104.00 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,955 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 20, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $2.08 | $24.96 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,905 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 19, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.05 | $112.75 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,893 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 18, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.96 | $107.80 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,838 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 17, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.24 | $123.20 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,783 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 16, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.03 | $111.65 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,728 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 13, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.07 | $113.85 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,673 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 12, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.13 | $117.15 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,618 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 11, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.04 | $112.20 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,563 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 10, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.04 | $112.20 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,508 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 09, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $2.06 | $113.30 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,453 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 06, 2023 Filed Nov 3, 2023 21:05 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 55 | $1.88 | $103.40 |
DisclosureSEC source: 0001214659-23-014542 · marketforms-63459.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,398 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.